• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail
-

Patent and Exclusivity Search Results from query on Appl No 020903 Product 002 in the OB_Rx list.


Patent Data

Appl No Prod No Patent No Patent
Expiration
Drug Substance
Claim
Drug Product
Claim
Patent Use
Code
Delist
Requested
N020903 002 6172046 Sep 21, 2017 U - 377
N020903 002 6172046 Sep 21, 2017 U - 1014
N020903 002 6172046*PED Mar 21, 2018
N020903 002 6177074 Nov 1, 2016 U - 454
N020903 002 6177074 Nov 1, 2016 U - 1013
N020903 002 6177074*PED May 1, 2017
N020903 002 6461605 Nov 1, 2016 U - 478
N020903 002 6461605 Nov 1, 2016 U - 1013
N020903 002 6461605*PED May 1, 2017
N020903 002 6472373 Sep 21, 2017 U - 479
N020903 002 6472373 Sep 21, 2017 U - 1014
N020903 002 6472373*PED Mar 21, 2018
N020903 002 6524570 Nov 1, 2016 U - 499
N020903 002 6524570 Nov 1, 2016 U - 1013
N020903 002 6524570*PED May 1, 2017

Exclusivity Data

There is no unexpired exclusivity for this product.


Additional information:

  1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
  2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be flagged with respect to other claims which may apply.


View a list of all patent use codes
View a list of all exclusivity codes

Return to Electronic Orange Book Home Page


FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through June 2014
Patent and Generic Drug Product Data Last Updated July 24, 2014

-
-